CoMIT pamphlet 2025
29/44

Research and Development DepartmentResponsible DepartmentResearch Partner286F 0604, 0912B• Search for biomarkers of the state of refractory neurological diseases and effect of drug treatment• Basic research on drug development for refractory neurological diseases• Search for new drug targets in refractory neurological diseasesFrustratingly, little is known about the causes of many neurological diseases and little is available in terms of treatment. In this course, we examine the pathology of several neurological diseases, the use of animal models to study the disease, and consider potential drug targets and biomarkers. Studies involve basic and clinical research.A-21The Center of Medical Innovation and Translational ResearchDepartment of Molecular NeuroscienceDepartment of Neuro-Medical ScienceITOKAZU TakahideSpecially Appointed ProfessorYAMASHITA ToshihideProfessorDepartment of Neuro-Medical ScienceMitsubishi Tanabe Pharma CorporationThe Center of Medical Innovation and Translational ResearchNew drugs for refractory neurological diseases through translational researchImmunity and Regeneration Integration UnitAttempts to develop novel concept therapies through the integration of immunology and regenerative medicine.

元のページ  ../index.html#29

このブックを見る